These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6620271)

  • 21. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
    Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of synovial fluid on lymphocyte functions in rheumatoid arthritis.
    Dolganiuc A; Stavaru C; Radu DL; Olinescu A
    Roum Arch Microbiol Immunol; 1998; 57(3-4):243-54. PubMed ID: 11845436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis].
    Nasonov EL; Samsonov MIu; Chichasova NV; Imametdinova GR; Nikiforova EL; Aleksandrova EN; Ilich-Stoyanovich O; Fux D; Vaxter H
    Ter Arkh; 1998; 70(5):28-31. PubMed ID: 9644738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of rheumatoid arthritis with gold preparations under control of their concentration in the blood serum].
    Beresten' TI; Trofimova TM
    Ter Arkh; 1980; 52(2):102-6. PubMed ID: 7376087
    [No Abstract]   [Full Text] [Related]  

  • 25. Amperometric titration of sulphydryl groups in human haemoglobin with silver nitrate.
    HOMMES FA; HUISMAN TH
    Biochem J; 1958 Feb; 68(2):312-4. PubMed ID: 13522620
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood total sulphydryl groups in human beings after surgery.
    Gupta ML; Khuteta KP; Mathur KN
    J Indian Med Assoc; 1970 Sep; 55(6):199-201. PubMed ID: 5501468
    [No Abstract]   [Full Text] [Related]  

  • 27. [Blood sulphydryl group in diseases of the diencephaloaxial divisions of the brain].
    Makarchenko OF; Dinaburg GD; Roitrub BA; Ugeev OF
    Fiziol Zh; 1967; 13(1):27-33. PubMed ID: 5620873
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of therapy, serology, stage and activity of rheumatoid arthritis on lymphocyte stimulation in whole blood].
    Fritze U; Fritze D; Bicker U; Ewald RW; Friedberg KD
    Z Rheumatol; 1983; 42(3):101-3. PubMed ID: 6880408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA rheumatoid factor correlates with changes in B and T lymphocyte subsets and disease manifestations in rheumatoid arthritis.
    Raza K; Karokis D; Kitas GD
    J Rheumatol; 1997 Nov; 24(11):2262-3. PubMed ID: 9375896
    [No Abstract]   [Full Text] [Related]  

  • 31. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
    Gao IK; Scholz P; Boehme MW; Norden C; Lemmel EM
    Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphocyte blast transformation according to the clinical variant of rheumatoid arthritis].
    Popova L; Pekhlivanov D; Matev M; Apostolov P; Sheĭtanov I
    Vutr Boles; 1980; 19(2):39-43. PubMed ID: 6966867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
    Laurent MR; Panayi GS
    Agents Actions Suppl; 1980; 7():310-7. PubMed ID: 7018201
    [No Abstract]   [Full Text] [Related]  

  • 34. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis.
    Ruth JH; Rottman JB; Kingsbury GA; Coyle AJ; Haines GK; Pope RM; Koch AE
    Cytometry A; 2007 May; 71(5):317-26. PubMed ID: 17323353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphydryl modifications alter scramblase activity in murine sickle cell disease.
    de Jong K; Kuypers FA
    Br J Haematol; 2006 May; 133(4):427-32. PubMed ID: 16643451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of immunotropic effect of the drug composition Taban-Arshan (Tibet medicine) on lymphocytes of patients with early rheumatoid arthritis and atopic bronchial asthma].
    Semenova LIu; Salmasi ZhM; Kazimirskiĭ AN; Poriadin GV
    Patol Fiziol Eksp Ter; 2005; (1):23-5. PubMed ID: 15801236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malondialdehyde as a sensitive marker of inflammation in patients with rheumatoid arthritis.
    Kalavacherla US; Ishaq M; Rao UR; Sachindranath A; Hepsiba T
    J Assoc Physicians India; 1994 Oct; 42(10):775-6. PubMed ID: 7876045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal levels of DHEAS as a marker for disease activity in premenopausal women with recent onset rheumatoid arthritis.
    Josipovic B; Josipovic A
    J Rheumatol; 2002 Aug; 29(8):1803-5. PubMed ID: 12180752
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
    Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
    Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rheumatoid arthritis--possible risk marker of cardiovascular disease].
    Jonsson SW; Dahlqvist SR
    Lakartidningen; 2004 Nov; 101(46):3672, 3674-5. PubMed ID: 15586491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.